Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs

Circulation. Cardiovascular Interventions
Fatih ArslanDominique P V de Kleijn

Abstract

Toll-like receptor (TLR)-2 is an important mediator of innate immunity and ischemia/reperfusion-induced cardiac injury. We have previously shown that TLR2 inhibition reduces infarct size and improves cardiac function in mice. However, the therapeutic efficacy of a clinical grade humanized anti-TLR2 antibody, OPN-305, in a large-animal model remained to be addressed. Pigs (n=38) underwent 75 minutes ischemia followed by 24 hours of reperfusion. Saline or OPN-305 (12.5, 6.25, or 1.56 mg/kg) was infused intravenously 15 minutes before reperfusion. Cardiac function and geometry were assessed by echocardiography. Infarct size was calculated as the percentage of the area at risk and by serum Troponin-I levels. Flow cytometry analysis revealed specific binding of OPN-305 to porcine TLR2. In vivo, OPN-305 exhibited a secondary half-life of 8±2 days. Intravenous administration of OPN-305 before reperfusion significantly reduced infarct size (45% reduction, P=0.041) in a dose-dependent manner. In addition, pigs treated with OPN-305 exhibited a significant preservation of systolic performance in a dose-dependent fashion, whereas saline treatment completely diminished the contractile performance of the ischemic/reperfused myocardium. OPN-3...Continue Reading

References

Nov 1, 1985·The Journal of Clinical Investigation·E Braunwald, R A Kloner
Mar 1, 1973·The Journal of Clinical Investigation·P LibbyE Braunwald
Dec 8, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·G Bernardi
Apr 16, 2002·Science·Polly Matzinger
Jun 3, 2004·Nature Reviews. Immunology·Seung-Yong Seong, Polly Matzinger
Jul 24, 2004·Circulation Research·Roberto BolliUNKNOWN NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia
Sep 19, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Yasushi SakataDouglas L Mann
Dec 26, 2006·Cardiovascular Research·Rainer KlockeSigrid Nikol
Mar 3, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Julie FavreVincent Richard
Apr 18, 2007·The American Journal of Cardiology·Abhiram PrasadBernard J Gersh
Jul 17, 2007·The American Journal of Cardiology·Anne BautersUNKNOWN REVE Investigators
May 14, 2008·Current Pharmaceutical Design·Fatih ArslanGerard Pasterkamp
Jul 16, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nikolaos G Frangogiannis
Nov 18, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Wei Chao
Nov 1, 2007·Stem Cell Research·Leo TimmersDominique P V de Kleijn
Apr 10, 2010·Nature Reviews. Drug Discovery·Elizabeth J HennessyLuke A J O'Neill
May 1, 2010·Journal of Innate Immunity·Mihaela G IonitaGerard Pasterkamp
Jul 16, 2010·Mediators of Inflammation·F ArslanA E Parker
Mar 31, 2011·Nature Reviews. Cardiology·Fatih ArslanGerard Pasterkamp

❮ Previous
Next ❯

Citations

Jul 3, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Giulio PoddaBruno Gran
May 3, 2013·Current Atherosclerosis Reports·Amos BaruchJoshua E Lehrer-Graiwer
Oct 22, 2013·Trends in Pharmacological Sciences·Jennifer E ColeClaudia Monaco
Dec 24, 2013·Mediators of Inflammation·J J de HaanF Arslan
Jul 25, 2013·International Journal of Molecular Sciences·Mika Falck-HansenClaudia Monaco
Aug 13, 2013·Oncogene·J-P PradereR F Schwabe
Oct 1, 2015·Expert Opinion on Therapeutic Targets·Gerardus P J van HoutImo E Hoefer
Mar 31, 2015·International Journal of Molecular Medicine·Tamilselvan SubramaniParasuraman Padmanabhan
Dec 26, 2015·Pharmacology & Therapeutics·Yu WangPaul M Vanhoutte
Apr 15, 2015·Proceedings of the National Academy of Sciences of the United States of America·Pragnesh MistryStefanie N Vogel
Sep 5, 2012·Trends in Pharmacological Sciences·Janelle Drouin-Ouellet, Francesca Cicchetti
Jul 4, 2012·Current Opinion in Pharmacology·Dympna J Connolly, Luke A J O'Neill
Aug 9, 2013·Clinical Transplantation·Demetra S TsapepasLloyd E Ratner
Jan 1, 2014·BioFactors·Emma KayJames R Whiteford
Dec 17, 2014·European Journal of Clinical Investigation·Stefan KoudstaalSteven A J Chamuleau
Dec 30, 2014·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jason M AliGavin J Pettigrew
Mar 28, 2013·Pharmacology & Therapeutics·Jing LiHang Yin
Nov 14, 2013·Clinical Science·Steven O'Reilly
Jul 15, 2015·Seminars in Immunopathology·Nicola Fullard, Steven O'Reilly
Nov 30, 2014·Current Hypertension Reports·Carmen De MiguelDavid L Mattson
May 3, 2016·Expert Opinion on Therapeutic Patents·Mahesh Chandra Patra, Sangdun Choi
Jun 5, 2016·Critical Care : the Official Journal of the Critical Care Forum·Alexander AsmussenSebastian Grundmann
Aug 16, 2016·Archives of Pharmacal Research·Asma AchekSangdun Choi
May 18, 2013·Nature Reviews. Immunology·Luke A J O'NeillAndrew G Bowie
Aug 31, 2013·Journal of Leukocyte Biology·Jeroen van BergenhenegouwenArjan P Vos
Jun 25, 2016·Circulation Research·Sumanth D Prabhu, Nikolaos G Frangogiannis
Jan 17, 2015·Circulation Research·Sebastian ZimmerEicke Latz
Apr 19, 2012·Circulation. Cardiovascular Interventions·Philipp M Lepper, Robert Bals
Nov 20, 2018·Medicinal Research Reviews·Muhammad Ayaz AnwarSangdun Choi
Dec 24, 2018·Cardiovascular Research·Coert J ZuurbierSean M Davidson
Sep 4, 2015·Journal of the American Society of Nephrology : JASN·Shrikant R MulayHans-Joachim Anders
Dec 10, 2013·Current Opinion in Organ Transplantation·Huiling Wu, Steven J Chadban
Apr 15, 2020·The Journal of Clinical Investigation·Maria Agustina BattistoneSylvie Breton
Apr 11, 2017·Cardiovascular Research·Kazuhiko Nishida, Kinya Otsu
Jan 31, 2020·Frontiers in Molecular Neuroscience·Chao ZhengTao Jin
Sep 29, 2020·Frontiers in Oncology·Asunción Espinosa-SánchezAmancio Carnero
Feb 20, 2016·Rheumatology·Lorraine O'Neill, Eamonn S Molloy
Sep 19, 2018·BioMed Research International·Wioletta OlejarzGrażyna Nowicka

❮ Previous
Next ❯

Related Concepts